Oxford, UK: The funding comes from existing investors and new investors, including International Holdings Company (IHC) and RPMI Railpen. The funds will support the rapid acceleration of Oxford Nanopore’s commercial and manufacturing operations as well as ongoing innovation in the field of nanopore technology. “We are delighted to welcome our new shareholders,” said Dr Gordon […]
IP Group plc – Portfolio company Oxford Nanopore Technologies announces £84.4m of additional funding
IP Group plc (LSE: IPO) (“IP Group” or “the Group”), the developer of intellectual property-based businesses, notes that its portfolio company Oxford Nanopore Technologies Ltd (“Oxford Nanopore” or “the Company”) has announced that it has raised an additional £84.4 million of new capital from existing and new investors including International Holdings Company (IHC) and RPMI […]
Partnership Combines Twist’s Leadership in DNA Synthesis and Synthetic Biology with Neogene’s Expertise in Personalized Engineered T Cell Therapies SOUTH SAN FRANCISCO, Calif. & AMSTERDAM & NEW YORK–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, and Neogene Therapeutics, Inc., a biotechnology […]
Automated Ionic® Cells to Pure DNA Low Input Kit consistently recovers up to twice the amount of high-quality nucleic acid from as few as 10 cultured or sorted cells Pleasanton, Calif. – Purigen Biosystems, Inc., a leading provider of next-generation technologies for extracting and purifying nucleic acids from biological samples, today announced the launch of […]
CANTON, Mass. — Universal Sequencing Technology Corporation (‘UST’), a developer of Next Generation Sequencing (NGS) technologies, today is proud to announce a commercial relationship with Shanghai Bioscience Ltd. for the distribution of TELL-Seq WGS Library preparation kits in China. The TELL-Seq kit allows customers to transform their short-read DNA sequencer into a long-read DNA sequencer. The method […]
The multiplex you have been waiting for! Amplification primers for eleven loci are multiplexed in three tubes. The three-tube design results in lower noise levels, better-balanced alleles, and higher quality compared to a one-tube approach. This means more reliable typing results. From DNA to results in only 1,5 days! Start your amplification on day 1 […]
Oxford Nanopore, the Bill & Melinda Gates Foundation, US CDC, Microsoft and Illumina collaborate with the Africa Centres for Disease Control and Prevention (Africa CDC) to launch Africa Pathogen Genomics Initiative (Africa PGI) $100 million four-year initiative will rapidly expand access to next-generation genomic sequencing tools and strengthen public health surveillance networks across Africa Oxford […]
Licenses aim to accelerate drug discovery leading to development of new therapies PanCELLa agreement marks MilliporeSigma’s first CRISPR license for bioproduction Takara Bio USA agreement gives access to MilliporeSigma’s CRISPR integration and vector technologies for Takara’s vector products and cell engineering services MilliporeSigma today announced that it has signed agreements licensing its CRISPR technology to two […]
Joins Africa CDC alongside the Bill & Melinda Gates Foundation and others in a four-year plan October 12, 2020 A dangerous novel pathogen emerging in any region is devastating, but even more so when genomics and bioinformatics infrastructure is insufficient to identify, monitor, or slow its spread. In resource-limited environments, public health officials struggle to allocate […]
LamPORE is a new, rapid, scalable, accurate test, for the detection of the SARS-CoV-2 virus that causes COVID-19. LamPORE is designed to be performed on a desktop device, GridION, or a palm-sized device, MinION Mk1C. Following an application to the UK’s MHRA, the LamPORE assay is now CE marked for in vitro diagnostic use for […]
Pay Invoice
Latest Blogs
-
SDi Predicts a Recovery Amid Headwinds
July 24, 2026 2:51 pm
-
EU Roadmap Provides Further Impetus for New Approach Methodologies
June 29, 2026 12:56 pm
-
MOBILion Expands into Proteomics MS Market
April 30, 2026 5:05 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
